
Ebrika D 30mg/20mg Capsule SR
Marketer
Erika Remedies
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Ebrika D 30mg/20mg Capsule SR
Gastro-esophageal reflux disease (GERD), or acid reflux, can be managed with the combined medication Ebrika D 30mg/20mg SR capsules. This formulation alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion, thus easing discomfort. Ebrika D 30mg/20mg SR capsules should be taken on an empty stomach, following your physician's prescribed dosage and duration. Treatment length depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and worsening GERD. Inform your healthcare provider of all other medications you're using, as interactions may occur. Common side effects, such as diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue, are generally transient. Report any concerning side effects immediately to your doctor. Drowsiness and dizziness are possible; avoid driving or activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle changes, including consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, may enhance treatment effectiveness. Prior to initiating treatment, disclose any kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of Ebrika D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Ebrika D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire capsule without chewing, crushing, or breaking it. Ebrika D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
Common Side effects of Ebrika D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Ebrika D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Ebrika D 30mg/20mg SR Capsule whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
How Ebrika D 30mg/20mg Capsule SR works:
Ebrika D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, acting synergistically to alleviate gastrointestinal distress. Domperidone, a prokinetic agent, enhances upper gastrointestinal motility, facilitating efficient food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid production, providing relief from acid reflux and indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Ebrika D 30mg/20mg SR capsules with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Ebrika D 30mg/20mg sustained-release capsules during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Ebrika D 30mg/20mg capsule is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Ebrika D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Ebrika D 30mg/20mg sustained-release capsules cautiously. Dosage modification for Ebrika D 30mg/20mg sustained-release capsules may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Ebrika D 30mg/20mg SR capsules; dosage modification may be necessary. Consult a physician before use. Ebrika D 30mg/20mg SR capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Ebrika D 30mg/20mg Capsule SR :
Should you forget a dose of Ebrika D 30mg/20mg sustained-release capsules, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ebrika D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
